章津铭
个人简介：
章津铭，教授，现任成都中医药大学药学院/现代中药产业学院副院长。主要研究方向为中药新型纳米递药系统及中医药健康产品开发。省部级优秀人才计划入选者、中国科协第四届青年人才托举工程人选、四川省杰出青年科技人才、四川省“特聘专家”、四川省中医药管理局学术技术带头人，荣获全国高等中医药院校优秀青年、四川省优秀党务工作者、四川省五四青年教师榜样等荣誉。承担国家自然科学基金面上项目基金、青年科学基金、中国博士后科学基金面上资助项目、中国博士后科学基金特别资助项目、四川省杰出青年科技人才项目等国家级、省部级等项目。以第一作者或通讯作者在adv drug deliv rev、acta pharm sin b、theranostics等学术期刊发表sci论文100余篇，入选2020年度、2022年度“全球前2%顶尖科学家榜单”（药学领域）（h-index 35），获授权发明专利8项，参与编写教材及专著多部，担任chin chem lett、chin med、imeta等期刊青年编委，中华中医药学会第二届青年委员会委员、世中联中药新型给药系统专业委员会常务理事等。
部分代表性成果如下：
1. quan gao, jiao feng, wencheng liu, chengyong wen, yihan wu, qian liao, liang zou, xinbing sui, tian xie, jinming zhang*, yichen hu*. opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment[j]. adv drug deliv rev. 2022, 188: 114445.
2. yihan wu, jiaxin li, liang zou, chaomei fu, meiwan chen, jinming zhang*, huile gao. a ph-sensitive supramolecular nanosystem with chlorin e6 and triptolide co-delivery for chemo-photodynamic combination therapy[j]. asian j pharm sci. 2022, 17(02): 206-218.
3. qian liao, lan pang, jing-jing li, chen zhang, jia-xing li, xing zhang, ting mao, ding-tao wu, xiu-ying ma, fu-neng geng, jin-ming zhang*. characterization and diabetic wound healing benefits of protein-polysaccharide complexes isolated from an animal ethno-medicine periplaneta americana l[j]. int j biol macromol. 2022, 195: 466-474.
4. jinfeng shi#, yali ren#, jiaqi ma, xi luo, jiaxin li, yihan wu, huan gu, chaomei fu, zhixing cao*, jinming zhang*. novel cd44-targeting and ph/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis[j]. j nanobiotechnology. 2021, 19(01): 188.
5. xiao wang, huan gu, huan zhang, jing xian, jingjing li, chaomei fu, chen zhang, jinming zhang*. oral core-shell nanoparticles embedded in hydrogel microspheres for the efficient site-specific delivery of magnolol and enhanced antiulcerative colitis therapy[j]. acs appl mater interfaces. 2021, 13(29): 33948-33961.
6. liang zou , xiaowei liu, jingjing li, wei li, lele zhang, chaomei fu, jinming zhang∗, zhongwei gu∗. redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy [j]. theranostics, 2021, 11(09): 4171.
7. yaoyao luo#, jingjing li#, yichen hu, fei gao, george pak-heng leung, funeng geng, chaomei fu*, jinming zhang*. injectable thermo-responsive nano-hydrogel loading triptolide for the anti-breast cancer enhancement via localized treatment based on “two strikes” effects[j]. acta pharm sin b, 2020, 10(11): 2227-2245.
8. xiaoqin yang, yihan wu, chen zhang, shu fu, jinming zhang*, fu chaomei*. extraction, structural characterization, and immunoregulatory effect of a polysaccharide fraction from radix aconiti lateralis preparata (fuzi)[j]. int j biol macromol, 2020, 143: 314-324.
9. jingjing li#, yihan wu#, di wang, liang zou, chaomei fu, jinming zhang*, leung george pak-heng*. oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects[j]. pharmacol res, 2019, 146: 104313.
10. jinming zhang, jingjing li, zhi shi, yang yang, xi xie, simon mingyuen lee*, yitao wang, kam w leong, meiwan chen*. ph-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities[j]. acta biomaterialia, 2017, 58: 349-364.